These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 10836289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity.
    Bressan RA, Jones HM, Pilowsky LS.
    J Psychopharmacol; 2004 Mar; 18(1):124-7. PubMed ID: 15107196
    [Abstract] [Full Text] [Related]

  • 4. Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan.
    Rizos EN, Chatziioannou S, Douzenis A, Siafakas N, Katsantoni E, Nikolaidou P, Papathanasiou M, Lykouras L.
    Eur Neuropsychopharmacol; 2010 Feb; 20(2):132-6. PubMed ID: 19740630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S, Kapur S, Tauscher J, Jones C, Daskalakis ZJ, Papatheodorou G, Epstein I, Christensen BK, Zipursky RB.
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.
    Alptekin K, Kivircik BB.
    Int Clin Psychopharmacol; 2002 Sep; 17(5):263-4. PubMed ID: 12177588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.
    Gourzis P, Polychronopoulos P, Papapetropoulos S, Assimakopoulos K, Argyriou AA, Beratis S.
    Clin Neuropharmacol; 2005 Sep; 28(4):195-6. PubMed ID: 16062102
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E, Douzenis A, Gournellis R, Christodoulou C, Lykouras LP.
    World J Biol Psychiatry; 2009 Sep; 10(1):54-7. PubMed ID: 19673087
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia.
    Gefvert O, Bergström M, Långström B, Lundberg T, Lindström L, Yates R.
    Psychopharmacology (Berl); 1998 Jan; 135(2):119-26. PubMed ID: 9497016
    [Abstract] [Full Text] [Related]

  • 19. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR, Link CG, Goldstein JM, Arvanitis LA.
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract] [Full Text] [Related]

  • 20. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V.
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.